Tafinlar (Dabrafenib) 50mg/75mg Capsules | BRAF Inhibitor | Novartis Turkey | GLT

Tafinlar is the originator brand of dabrafenib, the selective BRAF kinase inhibitor discovered and marketed globally by Novartis. This listing covers the Turkish-market presentation, supplied as 50 mg and 75 mg hard capsules in blister packs of 120. Turkey sits within Novartis's Middle East and Africa commercial region, and the packs distributed there carry Turkish-language labeling while meeting the same manufacturing and quality specifications as Tafinlar sold elsewhere in the world.

Generic Information: Tafinlar (Turkey)

The two capsule strengths shown here — 50 mg and 75 mg — are the standard building blocks used to reach the 150 mg twice-daily dose. Physicians use them for patients whose tumors carry a BRAF V600 mutation: melanoma that cannot be removed by surgery or has spread, non-small cell lung cancer with a BRAF V600E change, and anaplastic thyroid cancer with the same mutation. The flexibility of having both strengths on hand lets a clinic adjust dosing precisely.

What Is Tafinlar (Dabrafenib) Used For?

A fixed 150 mg capsule would be simpler, but dabrafenib is not made that way. The 75 mg and 50 mg capsules exist so a full 150 mg dose can be assembled as two 75 mg capsules, while the 50 mg size supports dose reductions when a patient develops fever or other side effects. Buying the Turkish pack therefore gives access to the complete dosing toolkit rather than a single fixed strength.

How Does Tafinlar Work?

Roughly half of cutaneous melanomas carry a BRAF V600E mutation that keeps the MAPK signaling pathway switched on. Tafinlar locks onto the mutated BRAF enzyme and turns that signal off, which slows tumor growth and can trigger cancer-cell death. Combining it with trametinib, a MEK inhibitor that acts one step downstream, blocks the same pathway at two points and is the standard first-line approach for advanced BRAF-mutant melanoma.

Indications

• Unresectable or metastatic melanoma with BRAF V600E or V600K mutation
• Adjuvant therapy after complete resection of BRAF-mutant melanoma
• Metastatic NSCLC with BRAF V600E mutation, in combination with trametinib
• Anaplastic thyroid cancer with BRAF V600E mutation, in combination with trametinib

Dosage & Administration

The standard adult regimen is 150 mg twice daily, about 12 hours apart, with or without food. The two capsule strengths in this listing let a prescriber deliver that dose and step down smoothly if toxicity appears. Capsules should be swallowed whole with water and never crushed or opened. Any adjustment to dose or schedule must be directed by the treating oncologist.

Side Effects

Fever is the signature side effect of dabrafenib and may require temporary interruption. Other common reactions include fatigue, rash, nausea, headache, chills and joint pain. More serious events are new skin cancers, bleeding, heart-muscle problems, eye inflammation and high blood sugar. Regular dermatologic checks and temperature monitoring are part of standard care while on this medicine.

Storage & Handling

Keep the capsules at room temperature in their original blister packaging, away from moisture and direct light. Store out of the reach of children and never use them past the expiry date printed on the carton.

Why Choose the GLT?

• Originator Tafinlar in both strengths — the 50 mg and 75 mg capsules needed for full dosing and dose reduction.
• Authentic Novartis product — sourced with batch documentation and traceability.
• Global delivery — GLT ships to hospitals, importers and individual patients worldwide.

How to Order Tafinlar (Turkey) from GLT

1. Send the product name, the strengths you need and the quantity to WhatsApp +86 15234153837 or email [email protected].
2. GLT returns a formal quotation and delivery estimate.
3. Payment is completed through our secure channel (Hao Yi Lian / 好易联).
4. Goods dispatch with full batch documentation and tracking to delivery.

A valid prescription may be requested before dispatch. We serve licensed institutions and individual patients alike.

FAQ

1. Is this Tafinlar the genuine Novartis product?

Yes, this is the originator Tafinlar manufactured by Novartis for the Turkish market, supplied with batch documentation by GLT.

2. Can I buy just the 50 mg or just the 75 mg capsules?

This listing covers both strengths; tell GLT which strength and quantity you need and we will quote accordingly.

3. Is a prescription required?

Yes. Dabrafenib is a prescription cancer medicine, and a valid prescription may be requested before dispatch.